Interpharm Holdings, Inc.
IPAH · OTC
12/31/2007 | 9/30/2007 | 6/30/2007 | 3/31/2007 | |
|---|---|---|---|---|
| Revenue | $16,214 | $17,715 | $15,372 | $19,910 |
| % Growth | -8.5% | 15.2% | -22.8% | – |
| Cost of Goods Sold | $13,945 | $16,639 | $13,092 | $13,535 |
| Gross Profit | $2,269 | $1,076 | $2,280 | $6,375 |
| % Margin | 14% | 6.1% | 14.8% | 32% |
| R&D Expenses | $2,903 | $3,458 | $5,961 | $4,711 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $3,303 | $3,772 | $3,689 | $3,918 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $6,206 | $7,230 | $9,650 | $8,629 |
| Operating Income | -$3,937 | -$6,154 | -$7,370 | -$2,254 |
| % Margin | -24.3% | -34.7% | -47.9% | -11.3% |
| Other Income/Exp. Net | -$984 | -$742 | -$483 | -$344 |
| Pre-Tax Income | -$4,921 | -$6,896 | -$7,853 | -$2,598 |
| Tax Expense | $5,976 | $0 | $1,858 | -$746 |
| Net Income | -$10,897 | -$6,896 | -$9,711 | -$1,852 |
| % Margin | -67.2% | -38.9% | -63.2% | -9.3% |
| EPS | -0.21 | -0.1 | -0.153 | -0.04 |
| % Growth | -110% | 34.8% | -283.2% | – |
| EPS Diluted | -0.21 | -0.1 | -0.153 | -0.04 |
| Weighted Avg Shares Out | 66,738 | 66,196 | 65,311 | 65,380 |
| Weighted Avg Shares Out Dil | 66,738 | 66,196 | 65,311 | 65,380 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $963 | $934 | $883 | $573 |
| EBITDA | -$2,974 | -$5,220 | -$6,487 | -$1,681 |
| % Margin | -18.3% | -29.5% | -42.2% | -8.4% |